Characterization of atrial and ventricular remodeling in an improved minimally invasive mouse model of transverse aortic constriction

Abstract

Introduction: Heart failure (HF) is the leading cause of death worldwide. Most large and small animal disease models of HF are based on surgical procedures. A common surgical technique to induce HF is transverse aortic constriction (TAC), which induces pressure overload. The conventional TAC (cTAC) procedure is a highly invasive surgery that is associated with severe inflammation and excessive perioperative deaths.

Aim: To establish an improved, minimally invasive TAC (mTAC) procedure that does not require thoracotomy.

Methods and results: Following anesthesia, mice were intubated, and a small incision was made at the neck and chest. After cutting the sternum about 4 mm, the aortic arch was approached without opening the pleural cavity. A suture was placed between the brachiocephalic artery and the left common carotid artery. This model was associated with low perioperative mortality and a highly reproducible constriction evidenced by an increased right-to-left carotid blood flow velocity ratio in mTAC mice (5.9 ± 0.2) vs. sham controls (1.2 ± 0.1; P < 0.001). mTAC mice exhibited progressive cardiac remodeling during the 8 weeks post-TAC, resulting in reduced left ventricular (LV) contractility, increased LV end-systolic diameter, left atrial enlargement and diastolic dysfunction, and an increased heart weight to tibia length ratio (mTAC: 15.0 ± 0.8 vs. sham: 10.1 ± 0.6; P < 0.01).

Conclusion: Our data show that the mTAC procedure yields a highly reproducible phenotype consisting of LV contractile dysfunction and enlargement, combined with left atrial enlargement and diastolic dysfunction.

Potential impact of the findings: This model may be used to test the molecular mechanisms underlying atrial remodeling associated with HF development or to evaluate therapeutic strategies to treat these conditions.

Keywords

Atrial remodeling / atrial fibrillation / heart failure / mouse model / transverse aortic constriction

References

[1] McMurray JJ,Anker SD.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail2012;14:803-69

[2] Bozkurt B,Tsutsui H.Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.Eur J Heart Fail2021;23:352-80

[3] Keefe JA,Ni L,Dobrev D.In-depth characterization of a mouse model of postoperative atrial fibrillation.J Cardiovasc Aging2022;2:40 PMCID:PMC9632544

[4] Gunata M.Experimental heart failure models in small animals.Heart Fail Rev2023;28:533-54

[5] Houser SR,Murphy AM.Animal models of heart failure: a scientific statement from the American Heart Association.Circ Res2012;111:131-50

[6] Rockman HA,Harris AN.Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.Proc Natl Acad Sci USA1991;88:8277-81 PMCID:PMC52490

[7] Nakao Y,Hamaguchi M.O-ring-induced transverse aortic constriction (OTAC) is a new simple method to develop cardiac hypertrophy and heart failure in mice.Sci Rep2022;12:85 PMCID:PMC8742050

[8] deAlmeida AC,Wehrens XH.Transverse aortic constriction in mice.J Vis Exp2010;21:1729 PMCID:PMC3164086

[9] Hanif W,Su Y.Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure.Cardiovasc Pathol2017;30:27-37 PMCID:PMC5592139

[10] Zaw AM,Law HK.Minimally invasive transverse aortic constriction in mice.J Vis Exp2017;121:e55293 PMCID:PMC5409346

[11] Hu P,Swenson L,Abel ED.Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload.Am J Physiol Heart Circ Physiol2003;285:H1261-9

[12] Reddy AK,Martono C,Madala S.Pulsed doppler signal processing for use in mice: design and evaluation.IEEE Trans Biomed Eng2005;52:1764-70

[13] Li YH,Ochoa LN.Effect of age on peripheral vascular response to transverse aortic banding in mice.J Gerontol A Biol Sci Med Sci2003;58:B895-9

[14] Hadi AM,Schalij I.Rapid quantification of myocardial fibrosis: a new macro-based automated analysis.Anal Cell Pathol2010;33:257-69

[15] Nakamura M.Mechanisms of physiological and pathological cardiac hypertrophy.Nat Rev Cardiol2018;15:387-407

[16] Rai V,Agrawal S.Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.Mol Cell Biochem2017;424:123-45 PMCID:PMC5219849

[17] Tannu S,Yarde M,Ma X.Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice.J Pharmacol Toxicol Methods2020;106:106935

[18] Martin TP,Harvey AP.Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice.Exp Physiol2012;97:822-32

[19] Liu B,Gao M,Gong G.Modified protocol for A mouse heart failure model using minimally invasive transverse aortic constriction.STAR Protoc2020;1:100186 PMCID:PMC7757422

[20] Mitsos S,Dougeni E,Dougenis D.A critical appraisal of open- and closed-chest models of experimental myocardial ischemia.Lab Anim2009;38:167-77

[21] von Knorring J,Lindgren L.Cardiac arrhythmias and myocardial ischemia after thoracotomy for lung cancer.Ann Thorac Surg1992;53:642-7

[22] Bosch L,Bastemeijer M.The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis.Heart Fail Rev2021;26:1515-24 PMCID:PMC8510918

[23] Mohammed SF,Oehler EA.Variable phenotype in murine transverse aortic constriction.Cardiovasc Pathol2012;21:188-98 PMCID:PMC3412352

[24] Wu J,Li L.Early estimation of left ventricular systolic pressure and prediction of successful aortic constriction in a mouse model of pressure overload by ultrasound biomicroscopy.Ultrasound Med Biol2012;38:1030-9

[25] Lygate CA,Hulbert K.Serial high resolution 3D-MRI after aortic banding in mice: band internalization is a source of variability in the hypertrophic response.Basic Res Cardiol2006;101:8-16

[26] Melleby AO,Aronsen JM.A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice.Cardiovasc Res2018;114:1680-90

[27] Reynolds JO,Wang Q.Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca²⁺ release.Int J Cardiol2016;225:371-80 PMCID:PMC5101129

[28] Richards DA,Calamaras TD.Distinct phenotypes induced by three degrees of transverse aortic constriction in mice.Sci Rep2019;9:5844 PMCID:PMC6458135

[29] Rossi A,Bonapace S.Left atrial volume provides independent and incremental information compared with exercise tolerance parameters in patients with heart failure and left ventricular systolic dysfunction.Heart2007;93:1420-5 PMCID:PMC2016944

[30] Hsiao CS,Chiou FR.Early predicting improvement of severe systolic heart failure by left atrial volume.Heart Vessels2023;38:523-34

[31] Hao Z,Yuan M.The predictive value of changes in left atrial volume index for rehospitalization in heart failure with preserved ejection fraction.Clin Cardiol2023;46:151-8 PMCID:PMC9933114

[32] Pritchett AM,Jacobsen SJ,Karon BL.Diastolic dysfunction and left atrial volume: a population-based study.J Am Coll Cardiol2005;45:87-92

[33] Sun Y,Zhang Y.Reverse atrial remodeling in heart failure with recovered ejection fraction.J Am Heart Assoc2023;12:e026891 PMCID:PMC9939067

[34] De Jong AM,Vreeswijk-Baudoin I,Van Gilst WH.Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload.PLoS One2013;8:e72651 PMCID:PMC3765172

[35] Kondo H,Fukui A.Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation.J Cardiol2018;71:310-9

[36] Yamaguchi N,Narke D.Cardiac pressure overload decreases ETV1 expression in the left atrium, contributing to atrial electrical and structural remodeling.Circulation2021;143:805-20

[37] Li Z,Liu F.Atrial cardiomyopathy markers and new-onset atrial fibrillation risk in patients with acute myocardial infarction.Eur J Intern Med2022;102:72-9

[38] Chen X,Dai C.Effect of estimated plasma volume status and left atrial diameter on prognosis of patients with acute heart failure.Front Cardiovasc Med2023;10:1069864 PMCID:PMC9905108

[39] Zafar MR,Sunder SS.Left atrial appendage volume as a prognostic Indicator of long-term mortality in Cancer survivors treated with thoracic radiation.Cardiooncology2023;9:2 PMCID:PMC9840329

[40] Poulsen MK,Henriksen JE.Left atrial volume index: relation to long-term clinical outcome in type 2 diabetes.J Am Coll Cardiol2013;62:2416-21